Company intelligence / Profile preview

Sonus Microsystems

Vancouver, British Columbia, Canadasonusmicrosystems.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Sonus Microsystems is developing a wearable cardiac ultrasound patch using proprietary polymer-based MEMS transducer technology and AI-driven analytics. The product aims to enable remote, real-time cardiac monitoring for conditions such as congestive heart failure. The company has raised pre-seed funding and is currently advancing through product development and validation partnerships but has not yet reported clinical trial results or commercial launches.

Therapeutic areas: Cardiovascular
Modalities: DeviceAI-powered diagnostic deviceWearable medical device
Industry: Physiological Monitoring

Partnerships

Providence Health Care Ventures (PHCV) – partnership for clinical validation and commercialization of the wearable ultrasound technology in real-world settings

Beyond the preview

Go deeper on Sonus Microsystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonus Microsystems.

Explore the full profile